Patent intelligence · US
US 11534474
Oral compositions for bladder regulation and uses thereof
Oral compositions for bladder regulation and uses thereof
Patent details — US 11534474
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 27, 2022
- Expiration
- Dec 22, 2042
- Applicant
- AYTU BIOPHARMA, INC.
- Claims
- 26
- CPC classes
- A61K, A61K36/076, A61K36/21, A61K36/40
Quick answer
US 11534474 (Oral compositions for bladder regulation and uses thereof) is held by AYTU BIOPHARMA, INC.. Status: granted. Granted Dec 27, 2022. Expires Dec 22, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- AYTU BIOPHARMA, INC.
- Grant date
- Expiration
- Claims
- 26
- CPC classes
- A61K, A61K36/076, A61K36/21, A61K36/40, A61K36/54, A61K36/64
More from AYTU BIOPHARMA, INC.
Related pharmaceutical patents in our USPTO index.
-
US 10184931
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted -
US 9410913
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted -
US 9360446
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted
Frequently asked questions
What is US patent 11534474?
US 11534474 (Oral compositions for bladder regulation and uses thereof) is held by AYTU BIOPHARMA, INC.. Status: granted. Granted Dec 27, 2022. Expires Dec 22, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11534474?
AYTU BIOPHARMA, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does US 11534474 expire?
Our index shows an expiration date of Dec 22, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.